866-997-4948(US-Canada Toll Free)

Global Prostate Cancer Therapeutics Market to 2020

Published By :

Renub Research

Published Date : Nov 2015

Category :

Cancer

No. of Pages : 80 Pages

Global Prostate Cancer Therapeutics Market Overview

The prostate cancer drugs market is expected to nearly double by 2020, due to the introduction of new, more expensive drugs. Prostate Cancer is the most frequently diagnosed cancer in men. In terms of loss of life from any disease, prostate cancer ranks eleventh; and it ranks sixth in terms of cancer–related mortality in men. The prostate cancer market has a huge demand for new and novel drugs that address unmet needs such as improved survival time, less toxicity, increased progression free survival, increased effectiveness, and lower cost. The global market for the prostate cancer therapeutics market is increasing, driven primarily by the growth in the hormone–refractory prostate cancer therapeutics market. Although, the prostate cancer market faces some hindrances such as the high cost of prostate cancer drugs, the market for prostate cancer drugs is likely to rise in the future.
 
Global Prostate Cancer Drugs Analysis: Zytiga was the leading prostate cancer drugs in 2014 being followed by Xtandi drugs. In prostate cancer drugs market, Leuplin and Zoladex stand at the third and fourth position respectively in 2014, while Lupron stands at the fifth position in the same year. Bayer's cancer drug Xofigo is also increasing its market share. Decapeptyl, Taxotere, Jevtana and Provenge are the other popular prostate cancer drugs in the global market.

Renub Research report titled “Global Prostate Cancer Therapeutics Market to 2020” provides a comprehensive assessment of the fast–evolving, high–growth of Prostate Cancer Therapeutics Market. This 80 page report with35 Figures and 2 Tables analyses the Prostate Cancer Therapy Drugs Market, driving factors and challenges for prostate cancer market landscape.

The report covers the following:
 

1. Global Prostate Cancer – Hormonal Therapy Drugs Market

•  Luteinizing Hormone–Releasing Hormone (LHRH) Antagonists

1. Zytiga
2. Gonax

•  Luteinizing Hormone–Releasing Hormone (LHRH) Analogs

1. Lupron
2. Zoladex
3. Decapeptyl
4. Eligard
5. Vantas
6. Leuplin

•  Anti–Androgens  
1. Casodex
2. Xtandi or MDV3100
3. Xtandi US or MDV3100


2. Global Prostate Cancer Chemotherapy Drugs Market

1. Taxotere
2. Jevtana

3. Global Prostate Cancer Immunotherapy Drugs Market

1. Provenge

4. Global Prostate Cancer Targeted Therapy Drugs Market

1. Xofigo or Alpharadin

Table of Content

Executive Summary
Prostate Cancer - Overview
Prostate Cancer Introduction
Risk Factors
Age
Race
Family History/Genetics
Diet/Lifestyle Factors
Obesity
Infection/Inflammation of the Prostate Gland
Disease Symptoms
Diagnosis
Digital Rectal Exam (DRE)
Prostate Specific Antigen (PSA) Blood Test
Prostate Ultrasound and Biopsy
Bone Scan
CT Scan & MRI
PET & SPECT Scan
Lymph Node Biopsy
ProstaScint Scan
Stages of Prostate Cancer
Stage I
Stage II
Stage III
Stage IV
Global Prostate Cancer Drugs Market
Global Prostate Cancer Incidence
Global Prostate Cancer Drugs Market Share
Table Global - Prostate Cancer Drugs Market Share (Percent), 2011 – 2014
Table Global - Forecast for Prostate Cancer Drugs Market Share (Percent), 2015 – 2020
Global Prostate Cancer - Hormonal Therapy Drugs Sales & Forecast to 2020
Luteinizing Hormone - Releasing Hormone (LHRH) Antagonists
Zytiga
Gonax / Firmagon
Luteinizing Hormone - Releasing Hormone (LHRH) Analogs
Lupron
Zoladex
Decapeptyl
Eligard
Vantas
Leuplin
Anti - Androgens
Casodex
Xtandi or MDV3100
Xtandi US or MDV3100
Global Prostate Cancer - Chemotherapy Drugs Market
Taxotere
Jevtana
Global Prostate Cancer - Immunotherapy Drugs Market
Provenge
Global Prostate Cancer - Targeted Therapy Drugs Market
Xofigo or Alpharadin
Global Prostate Cancer Market - Driving Factors
Introduction of Innovative Drugs
Advancement in Oncology Therapeutic Area
Development in Genomics & Proteomics
Global Prostate Cancer Market - Challenges
Costly Prostate Cancer Drugs
Adverse Events of Treatment
Low Success Rate for Oncology Drugs

List of Table

NA

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *